Blind References:

  1. EMSAM prescribing information, Dey Pharma, L.P. May 2009.
  2. Depression. National Institute of Mental Health Web site. Available at: http://www.nimh.nih.gov/health/publications/depression/complete-index.shtml Updated September 23, 2010. Accessed March 9, 2011.
  3. Depression (major depression). Mayo Clinic Web site. Available at: http://www.mayoclinic.com/health/depression/DS00175. Updated February 11, 2010. Accessed March 9, 2011.
  4. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105.
  5. Stahl SM. Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. Second Edition. Cambridge University Press 2000.
  6. Depression and Bipolar Support Alliance. The Value of DBSA Support Groups. Available at: http://www.dbsalliance.org/site/PageServer?pagename=support_supportgroups Accessed July 7, 2011.
  7. National Suicide Prevention Hotline Web site. Available at: http://www.suicidepreventionlifeline.org/. Accessed June 30, 2011.
  8. Preskorn SH. Why the transdermal delivery of selegiline (6 mg/24 hr) obviates the need for a dietary restriction on tyramine. J Psychiatr Pract. 2006;12:168-172.
  9. Fiedorowicz JG, Swartz KL. The Role of Monoamine Oxidase Inhibitors in Current Psychiatric Practice. J Psychiatr Pract. 2004;10(4):239-248.
  10. Bodkin JA, Amsterdam JD. Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry. 2002;159:1869-1875.
  11. Amsterdam JD, Bodkin JA. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial. J Clin Psychopharmacol. 2006;26:579-586.
  12. Rush AJ, Trivedi MH, Wisniewski SR, et al, for the STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231-1242.
  13. Trivedi MH, Fava M, Wisniewski SR, et al, for the STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-1252.